GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 99 filers reported holding GENMARK DIAGNOSTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,026,000 | +12.0% | 42,926 | -31.6% | 0.01% | -14.3% |
| Q4 2020 | $916,000 | +65.6% | 62,745 | +61.3% | 0.01% | 0.0% |
| Q3 2020 | $553,000 | -66.2% | 38,910 | -65.1% | 0.01% | -73.1% |
| Q2 2020 | $1,638,000 | +169.9% | 111,335 | -24.4% | 0.03% | +62.5% |
| Q1 2020 | $607,000 | -46.6% | 147,258 | -37.7% | 0.02% | +128.6% |
| Q4 2019 | $1,137,000 | -33.7% | 236,413 | -16.4% | 0.01% | -53.3% |
| Q3 2019 | $1,715,000 | +45.1% | 282,946 | +55.3% | 0.02% | +25.0% |
| Q2 2019 | $1,182,000 | +246.6% | 182,178 | +278.8% | 0.01% | +200.0% |
| Q1 2019 | $341,000 | +348.7% | 48,094 | +244.9% | 0.00% | +300.0% |
| Q1 2018 | $76,000 | +46.2% | 13,943 | +11.7% | 0.00% | 0.0% |
| Q4 2017 | $52,000 | -69.6% | 12,480 | -10.8% | 0.00% | -85.7% |
| Q4 2016 | $171,000 | +216.7% | 13,986 | +37.1% | 0.01% | +75.0% |
| Q1 2016 | $54,000 | – | 10,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 3,365,000 | $16,186,000 | 1.49% |
| CADIAN CAPITAL MANAGEMENT, LP | 5,517,767 | $26,540,000 | 1.17% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 1,590,000 | $7,646,000 | 1.04% |
| Parkman Healthcare Partners LLC | 420,000 | $2,020,000 | 0.58% |
| Penn Capital Management Company, LLC | 977,526 | $4,702,000 | 0.49% |
| Bullseye Asset Management LLC | 79,272 | $381,000 | 0.37% |
| Bellevue Group AG | 2,441,241 | $11,742,000 | 0.19% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 300,783 | $1,447,000 | 0.18% |
| Granite Investment Partners, LLC | 589,313 | $2,835,000 | 0.13% |
| WRAPMANAGER INC | 68,163 | $328,000 | 0.10% |